Vaccination of Metastatic Renal Cancer Patients with MVA-5T4: A Randomized, Double-Blind, Placebo-Controlled Phase III Study

J. Amato, Robert; E. Hawkins, Robert; L. Kaufman, Howard; A. Thompson, John; Tomczak, Piotr; Szczylik, Cezary; McDonald, Mike; Eastty, Sarah; Shingler, William; de Belin, Jackie; Goonewardena, Madusha; Naylor, Stuart; Harrop, Richard

doi:10.1158/1078-0432.ccr-10-2082

Public

Vaccination of Metastatic Renal Cancer Patients with MVA-5T4: A Randomized, Double-Blind, Placebo-Controlled Phase III Study

Published in Clinical Cancer Research • Sep 30, 2010

Authors:

Robert J. Amato

Robert E. Hawkins

Howard L. Kaufman

Abstract

PURPOSE: The TroVax Renal Immunotherapy Survival Trial was a randomized, placebo-controlled phase III study that investigated whether modified vaccinia Ankara encoding the tumor antigen 5T4 (MVA-5T4) prolonged survival of patients receiving first-line standard-of-care (SOC) treatment for metastatic ...

Subject

Medicine

Placebo

Internal medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!